Range
575.61 - 594.22
Vol / Avg.
845.3K/779K
Div / Yield
-
52 Wk
441 - 686.62
Mkt Cap
63.3B
Payout Ratio
-
Open
579.14
P/E
10.37
EPS
29.51
Shares
107M
Outstanding
107M
Total Float
89M
Benzinga - Oct 14, 2021, 10:28AM
load more
Sector: Health Care.Industry: Biotechnology
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-04
REV
Q2 2021Est.ActualSurprise
EPS17.69025.800 8.1100
REV3.890B5.139B1.249B

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Regeneron Pharmaceuticals Questions & Anwsers

Q

How do I buy Regeneron Pharmaceuticals (REGN) stock?

A

You can purchase shares of Regeneron Pharmaceuticals (NASDAQ: REGN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Regeneron Pharmaceuticals's (REGN) competitors?

Q

What is the target price for Regeneron Pharmaceuticals (REGN) stock?

A

The latest price target for Regeneron Pharmaceuticals (NASDAQ: REGN) was reported by SVB Leerink on October 26, 2021. The analyst firm set a price target for 798.00 expecting REGN to rise to within 12 months (a possible 34.76% upside). 31 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Regeneron Pharmaceuticals (REGN)?

A

The stock price for Regeneron Pharmaceuticals (NASDAQ: REGN) is $592.15 last updated Tue Oct 26 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Regeneron Pharmaceuticals (REGN) pay a dividend?

A

There are no upcoming dividends for Regeneron Pharmaceuticals.

Q

When is Regeneron Pharmaceuticals (NASDAQ:REGN) reporting earnings?

A

Regeneron Pharmaceuticals’s $Q3 earnings are confirmed for after-market on $November 4, 2021.

Q

Is Regeneron Pharmaceuticals (REGN) going to split?

A

There is no upcoming split for Regeneron Pharmaceuticals.

Q

What sector and industry does Regeneron Pharmaceuticals (REGN) operate in?

A

Regeneron Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.